|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
A Phase I Study of Combination
of Intravenous Gemcitabine, Oxaliplatin, and 5-FU with Daily
Oral Thalidomide (GOFT) in Metastatic/Locally Advanced Pancreatic
Carcinoma Patients Hepatogastroenterology. 2007
Oct-Nov;54(79):2141-5. PMID: 18251177 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |